登革病毒实验室诊断方法研究进展

巩沅鑫; 郭红霞; 叶楠; 邱民月; 杨茂成; 李晋涛

doi:10.16462/j.cnki.zhjbkz.2020.01.017

登革病毒实验室诊断方法研究进展

doi: 10.16462/j.cnki.zhjbkz.2020.01.017

巩沅鑫^{1, 2},
郭红霞¹,
叶楠¹,
邱民月¹,
杨茂成¹,
李晋涛^1, ,

1.
400038 重庆, 陆军军医大学基础医学院军事生物安全教研室
2.
150080 哈尔滨, 中国人民解放军联勤保障部队第962医院检验科

基金项目: 国家自然科学基金(81570497)

详细信息

通讯作者:
李晋涛, E-mail:ljtqms@tmmu.edu.cn

中图分类号: R373.3
计量
- 文章访问数: 312
- HTML全文浏览量: 217
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2019-08-20
- 修回日期: 2019-10-04
- 刊出日期: 2020-01-10

Research progress of laboratory diagnostic methods of dengue virus

1.
Department of Military Biosafety, School of Basic Medical Sciences, Army Medical University, Chongqing 400038, China
2.
Clinical laboratory, the 962 Hospital of The PLA Joint Logistic Support Force, Harbin 150080, China

Funds: National Natural Science Foundation of China(81570497)

More Information

Corresponding author: LI Jin-tao, E-mail:ljtqms@tmmu.edu.cn

摘要

摘要: 目前登革病毒(dengue virus, DENV)已被世界卫生组织视为热带及亚热带地区的重大公共卫生问题。近年来全球范围内登革热疫情频发, 有愈演愈烈的趋势。仅2019年已在菲律宾、泰国、孟加拉国、缅甸及中国重庆市暴发了不同程度的登革热疫情。DENV的实验室诊断方法对于登革疫情的防控意义重大。为此本文对现阶段DENV实验室诊断方法及策略进行综述。通过回顾以往传统性诊断方法, 展望新兴的诊断策略, 为登革疫情暴发时选择合适的实验室诊断方案提供参考。
- DENV /
- 诊断 /
- RNA转染 /
- 基因编辑技术
Abstract: Dengue virus(DENV) has been identified by World Health Organization as a major public health problem in tropical and subtropical regions. In recent years, dengue outbreaks have become more and more frequent in the world. In 2019, dengue outbreaks of varying degrees have occurred in the Philippines, Thailand, Bangladesh, Myanmar and Chongqing City in China. The laboratory diagnostic method of DENV is of great significance to the prevention and control of dengue epidemic. Therefore, the methods and strategies of DENV laboratory diagnosis are reviewed in this paper. By reviewing the traditional diagnostic methods and looking forward to the emerging diagnostic strategies, this paper aims to provide a reference to select the appropriate laboratory diagnostic scheme for the outbreak of dengue.
- DENV /
- Diagnose /
- RNA transfection /
- CRISPR

HTML全文

参考文献(17)

[1]	Whitehorn J, Farrar J. Dengue[J]. Br Med Bull, 2010, 95(1): 161-173. DOI: 10.1093/bmb/ldq019.
[2]	Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue[J]. Nature, 2013, 496(7446): 504-507. DOI: 10.1038/nature12060.
[3]	Gunawardana SA, Shaw RH. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: panacea or pandora's box?[J]. BMC Infect Dis, 2018, 18(1): 641. DOI: 10.1186/s12879-018-3572-0.
[4]	重庆市卫生健康委员会.重庆市登革疫情防控工作通报[EB/OL]. (2019-09-06)[2019-09-08]. http://wsjkw.cq.gov.cn/tzgg/20190906/247518.html. Chongqing Municipal Health Commission.Notification of dengue epidemic prevention and control in Chongqing municipality[EB/OL].(2019-09-06)[2019-09-08].http://wsjkw.cq.gov.cn/tzgg/20190906/247518.html.
[5]	Chua KB, Mustafa B, Abdul WAH, et al. A comparative evaluation of dengue diagnostic tests based on single-acute serum samples for laboratory confirmation of acute dengue[J]. Malays J Pathol, 2011, 33(1): 13-20. http://www.ncbi.nlm.nih.gov/pubmed/21874746
[6]	Klungthong C, Gibbons RV, Thaisomboonsuk B, et al. Dengue virus detection using whole blood for reverse transcriptase PCR and virus isolation[J]. J Clin Microbiol, 2007, 45(8): 2480-2485. DOI: 10.1128/JCM.00305-07.
[7]	Lai SC, Huang YY, Shu PY, et al. Development of an enzyme-linked immunosorbent assay for rapid detection of dengue virus(DENV)NS1 and differentiation of DENV serotypes during early infection[J]. J Clin Microbiol, 2019, 57(7): e00221. DOI: 10.1128/JCM.00221-19.
[8]	Day PM, Thompson CD, Buck CB, et al. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition[J]. J Virol, 2007, 81(16): 8784-8792. DOI: 10.1128/JVI.00552-07.
[9]	León-Juárez M, García-Cordero J, Santos-Argumedo L, et al. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes[J]. APMIS, 2013, 121(9): 848-858. DOI: 10.1111/apm.12044.
[10]	Bessoff K, Delorey M, Sun W, et al. Comparison of two commercially available dengue virus(DENV)NS1 capture enzyme-linked immunosorbent assays using a single clinical sample for diagnosis of acute DENV infection[J]. Clin Vaccine Immunol, 2008, 15(10): 1513-1518. DOI: 10.1128/CVI.00140-08.
[11]	Luo YY, Feng JJ, Zhou JM, et al. Identification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibody[J]. BMC Microbiol, 2013, 13: 194. DOI: 10.1186/1471-2180-13-194.
[12]	Gelanew T, Hunsperger E. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4(DENV-4)non-structural protein(NS1)[J]. Virol J, 2018, 15(1): 30. DOI: 10.1186/s12985-018-0925-7.
[13]	Meyer D, Schmeiser S, Postel A, et al. Transfection of RNA from organ samples of infected animals represents a highly sensitive method for virus detection and recovery of classical swine fever virus[J]. PLoS One, 2015, 10(5): e0126806. DOI: 10.1371/journal.pone.0126806.
[14]	Belsham GJ, Jamal SM, Tj⌀rneh⌀j K, et al. Rescue of foot-and-mouth disease viruses that are pathogenic for cattle from preserved viral RNA samples[J]. PLoS One, 2011, 6(1): e14621. DOI: 10.1371/journal.pone.0014621.
[15]	Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity[J]. Science, 2018, 360(6387): 436-439. DOI: 10.1126/science.aar6245.
[16]	Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6[J]. Science, 2018, 360(6387): 439-444. DOI: 10.1126/science.aaq0179.
[17]	Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2[J]. Science, 2017, 356(6336): 438-442. DOI: 10.1126/science.aam9321.